Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions - SPIRIT III


The goal of the trial was to evaluate treatment with an everolimus-eluting stent compared with a paclitaxel-eluting stent among patients undergoing elective percutaneous coronary intervention (PCI) for de novo coronary lesions.